Home / Stocks / XLO

XLO insider trading

Xilio Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$1.9M
Buys · last 90 days
0 · $0
Most recent buy
2026-03-30

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-30Shannon James Samuel
Director
Bought5,000$8.79$44k
2025-06-18Shannon James Samuel
Director
Bought70,000$0.69$48k
2025-06-18Russo Rene
PRESIDENT AND CEO
Bought36,289$0.68$25k
2024-12-19GILEAD SCIENCES, INC.
10% owner
Bought1,759,978$1.04$1.8M

Most active insider buyers

InsiderRoleBuysTotal bought
GILEAD SCIENCES, INC.10% owner1$1.8M
Shannon James SamuelDirector2$92k
Russo RenePRESIDENT AND CEO1$25k

See XLO on the chart

Every insider buy and sell for XLO plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.